Literature DB >> 8600309

Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma.

P Selvanayagam1, S Rajaraman.   

Abstract

A cDNA isolated by a subtractive hybridization procedure detected loss of mtDNA and the mRNA coding for NADH dehydrogenase subunit 3 in 8 of 13 tumor kidney tissues obtained from patients with renal cell carcinoma. Sequencing revealed a stretch of nucleotides homologous to the mitochondrial NADH dehydrogenase subunit 3 gene in the middle of the cDNA. The depletion phenomenon was also observed in five of six renal carcinoma cell lines. In the case of a benign renal oncocytoma, however, the mtDNA content was increased 200% more than that of the adjacent normal tissue. The frequency with which this phenomenon occurs in renal cell carcinomas, but not in other types of cancers, suggests that this may be an important phenotype associated with renal cell neoplastic transformation. However, the absence of any structural alterations within the mitochondrial genome suggests that the depletion may be a secondary event associated with the oncogenic transformation process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600309

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  25 in total

1.  Silencing of IkBβ mRNA causes disruption of mitochondrial retrograde signaling and suppression of tumor growth in vivo.

Authors:  Weigang Tang; Anindya Roy Chowdhury; Manti Guha; Li Huang; Thomas Van Winkle; Anil K Rustgi; Narayan G Avadhani
Journal:  Carcinogenesis       Date:  2012-05-27       Impact factor: 4.944

Review 2.  Genetic insights into OXPHOS defect and its role in cancer.

Authors:  Dhyan Chandra; Keshav K Singh
Journal:  Biochim Biophys Acta       Date:  2010-11-11

Review 3.  Regulation of mitochondrial DNA content and cancer.

Authors:  Masahiro Higuchi
Journal:  Mitochondrion       Date:  2006-12-05       Impact factor: 4.160

Review 4.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

5.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

Authors:  T Tanaka; S Kondo; Y Iwasa; H Hiai; S Toyokuni
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  A novel role for mitochondria in regulating epigenetic modification in the nucleus.

Authors:  Dominic J Smiraglia; Mariola Kulawiec; Gaia L Bistulfi; Sampa Ghoshal Gupta; Keshav K Singh
Journal:  Cancer Biol Ther       Date:  2008-08-01       Impact factor: 4.742

7.  Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma.

Authors:  Jinliang Xing; Meng Chen; Christopher G Wood; Jie Lin; Margaret R Spitz; Jianzhong Ma; Christopher I Amos; Peter G Shields; Neal L Benowitz; Jian Gu; Mariza de Andrade; Gary E Swan; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2008-07-29       Impact factor: 13.506

8.  Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.

Authors:  Peng Xia; Han-Xiang An; Cheng-Xue Dang; Ramin Radpour; Corina Kohler; Emmanouil Fokas; Rita Engenhart-Cabillic; Wolfgang Holzgreve; Xiao Yan Zhong
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

9.  Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis.

Authors:  Keshav K Singh; Vanniarajan Ayyasamy; Kjerstin M Owens; Manika Sapru Koul; Marija Vujcic
Journal:  J Hum Genet       Date:  2009-07-24       Impact factor: 3.172

10.  Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

Authors:  Corina Kohler; Ramin Radpour; Zeinab Barekati; Reza Asadollahi; Johannes Bitzer; Edward Wight; Nicole Bürki; Claude Diesch; Wolfgang Holzgreve; Xiao Yan Zhong
Journal:  Mol Cancer       Date:  2009-11-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.